RecruitingNot ApplicableNCT06816641

Surgical Evacuation Of Spontaneous Intracerebral Hematoma: Clinical Outcomes and Prognostic Factors


Sponsor

Sohag University

Enrollment

40 participants

Start Date

Jan 1, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of this study is to assess the safety and efficacy of surgical evacuation of spontaneous intracerebral hemorrhage.


Eligibility

Min Age: 20 YearsMax Age: 70 Years

Inclusion Criteria2

  • • Patients with radiological findings of ICH.
  • Age group 20-70 years.

Exclusion Criteria8

  • • Traumatic ICH or ruptured aneurysm or AVM or brain tumor.
  • Postoperative cranial surgery ICH.
  • Secondary hydrocephalus.
  • Patients with other comorbidities e.g., Liver cell failure and renal cell failure.
  • Patients with bleeding disorders.
  • Patients who are regular on anticoagulant or antiplatelet therapy.
  • Small sized ICH\< 30 ml.
  • GCS less than 6 preoperatively.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURESurgical Evacuation of Intracerebral Hemorrhage

Surgical Evacuation of Intracerebral Hemorrhage


Locations(1)

Sohag University hospitals

Sohag, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06816641


Related Trials